Bruker Corporation Stock

$43.25

1.24% today

Nasdaq, Jul 14, 10:00 pm CET

ISIN

US1167941087

Symbol

BRKR

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Bruker Corporation Stock price

$43.79

+4.31 10.92% 5Y

Nasdaq, Closing price Fri, Jul 11 2025

+0.21 0.48%

ISIN

US1167941087

Symbol

BRKR

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P MidCap 400

Sector

Health

Industry

Medical specialties

Key metrics

Basic

Market capitalization

$6.6b

Enterprise Value

$8.6b

Net debt

$1.9b

Cash

$184.2m

Shares outstanding

151.5m

Valuation (TTM | estimate)

P/E

82.6 | 17.6

P/S

1.9 | 1.9

EV/Sales

2.5 | 2.4

EV/FCF

49.1

P/B

3.7

Dividends

DPS

$0.20

Yield 1Y | 5Y

0.5% | 0.3%

Growth 1Y | 5Y

0.0% | 4.6%

Payout 1Y | 3Y

26.3% | 10.6%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$3.4b | $3.6b

EBITDA

$578.2m | $668.9m

EBIT

$378.7m | $552.1m

Net Income

$79.6m | $376.6m

Free Cash Flow

$174.6m

Growth (TTM | estimate)

Revenue

14.8% | 6.5%

EBITDA

2.8% | 17.2%

EBIT

-13.6% | 42.7%

Net Income

-80.2% | 233.0%

Free Cash Flow

-3.6%

Financial Health

Equity Ratio

30.7%

Return on Equity

6.4%

ROCE

8.3%

ROIC

4.3%

Debt/Equity

1.2

EPS

$0.5

FCF per Share

$1.2

Short interest

14.1%

Employees

11k

Rev per Employee

$300.0k

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Get Started for Free Today

Bruker Corporation Stock Analysis

Unlock Scores for Free

??

21 Analysts have issued a Bruker Corporation forecast:

12x Buy

57%

8x Hold

38%

More details on Analyst Estimates Including Price Targets

21 Analysts have issued a Bruker Corporation forecast:

Buy

57%

Hold

38%

Sell

Analyst Estimates with Stock Price Targets

Financial data from Bruker Corporation

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	3,446 3,446	15% 15% 100%
- Direct Costs	1,748 1,748	17% 17% 51%
Gross Profit	1,698 1,698	12% 12% 49%
- Selling and Administrative Expenses	924 924	21% 21% 27%
- Research and Development Expense	392 392	27% 27% 11%
EBITDA	578 578	3% 3% 17%
- Depreciation and Amortization	200 200	60% 60% 6%
EBIT (Operating Income) EBIT	379 379	14% 14% 11%
Net Profit	80 80	80% 80% 2%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Bruker Corporation Stock News

Neutral

Business Wire

●

20 days ago

Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the shipment and installation of the 15th InSight WLI 3D optical metrology system to a leading semiconductor manufacturer. The installation is part of a larger order from this semiconductor manufacturer for 27 Bruker optical metrology systems in 2025. This reflects the growing demand for high-pe...

Neutral

Business Wire

●

about one month ago

Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (NASDAQ: BRKR) today announced that its Applied Mass Spectrometry (Applied MS) division will present a powerful lineup of innovations at the 73rd American Society for Mass Spectrometry (ASMS) Conference, taking place June 1–5, 2025, in Baltimore, Maryland. These developments reflect Bruker's continued investment in applied ma...

Neutral

Business Wire

●

about one month ago

Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics

INNSBRUCK, Austria--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (NASDAQ: BRKR) today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed. biocrates is a global leader in mass spectrometry (MS)-based quantitative metabolite and lipid analysis kits, assays, software and services that make standardized metabolomics acce...

More Bruker Corporation News

Company Profile

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.

Head office	United States
CEO	Frank Laukien
Employees	11,396
Founded	1960
Website	www.bruker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now